BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Vogel A, Gupta S, Zeile M, von Haken R, Brüning R, Lotz G, Vahrmeijer A, Vogl T, Wacker F. Chemosaturation Percutaneous Hepatic Perfusion: A Systematic Review. Adv Ther 2017;33:2122-38. [PMID: 27798773 DOI: 10.1007/s12325-016-0424-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Georgakis GV, Goldberg I, Sasson AR. Current Trends in the Surgical Management of Colorectal Cancer Liver Metastases. Curr Colorectal Cancer Rep 2019;15:135-41. [DOI: 10.1007/s11888-019-00440-4] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Dewald CLA, Meine TC, Winther HMB, Kloeckner R, Maschke SK, Kirstein MM, Vogel A, Wacker FK, Meyer BC, Renne J, Hinrichs JB. Chemosaturation Percutaneous Hepatic Perfusion (CS-PHP) with Melphalan: Evaluation of 2D-Perfusion Angiography (2D-PA) for Leakage Detection of the Venous Double-Balloon Catheter. Cardiovasc Intervent Radiol 2019;42:1441-8. [DOI: 10.1007/s00270-019-02243-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
3 Vogl TJ, Koch SA, Lotz G, Gebauer B, Willinek W, Engelke C, Brüning R, Zeile M, Wacker F, Vogel A, Radeleff B, Scholtz JE. Percutaneous Isolated Hepatic Perfusion as a Treatment for Isolated Hepatic Metastases of Uveal Melanoma: Patient Outcome and Safety in a Multi-centre Study. Cardiovasc Intervent Radiol 2017;40:864-72. [PMID: 28144756 DOI: 10.1007/s00270-017-1588-2] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 4.2] [Reference Citation Analysis]
4 Veelken R, Maiwald B, Strocka S, Petersen TO, Moche M, Ebel S, Denecke T, Rehak M, Struck MF, Forstmeyer D, Rademacher S, Seehofer D, Berg T, van Bömmel F. Repeated percutaneous hepatic perfusion with melphalan can maintain long-term response in patients with liver cancers. Cardiovasc Intervent Radiol 2021. [PMID: 34716470 DOI: 10.1007/s00270-021-02983-2] [Reference Citation Analysis]
5 Dewald CLA, Hinrichs JB, Becker LS, Maschke S, Meine TC, Saborowski A, Schönfeld LJ, Vogel A, Kirstein MM, Wacker FK. Chemosaturation with Percutaneous Hepatic Perfusion: Outcome and Safety in Patients with Metastasized Uveal Melanoma. Rofo 2021;193:928-36. [PMID: 33535258 DOI: 10.1055/a-1348-1932] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Lamarca A, Ross P, Wasan HS, Hubner RA, McNamara MG, Lopes A, Manoharan P, Palmer D, Bridgewater J, Valle JW. Advanced Intrahepatic Cholangiocarcinoma: Post Hoc Analysis of the ABC-01, -02, and -03 Clinical Trials. J Natl Cancer Inst. 2020;112:200-210. [PMID: 31077311 DOI: 10.1093/jnci/djz071] [Cited by in Crossref: 24] [Cited by in F6Publishing: 30] [Article Influence: 12.0] [Reference Citation Analysis]
7 Dewald CLA, Becker LS, Maschke SK, Meine TC, Alten TA, Kirstein MM, Vogel A, Wacker FK, Meyer BC, Hinrichs JB. Percutaneous isolated hepatic perfusion (chemosaturation) with melphalan following right hemihepatectomy in patients with cholangiocarcinoma and metastatic uveal melanoma: peri- and post-interventional adverse events and therapy response compared to a matched group without prior liver surgery. Clin Exp Metastasis 2020;37:683-92. [PMID: 33034815 DOI: 10.1007/s10585-020-10057-9] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Helmberger T. The evolution of interventional oncology in the 21st century. Br J Radiol 2020;93:20200112. [PMID: 32706978 DOI: 10.1259/bjr.20200112] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Frost JP, Najran P, Bell J, Mullan D. Radial Artery Access for Hepatic Chemosaturation: The First Description of Technical Feasibility. Cureus 2021;13:e18852. [PMID: 34671515 DOI: 10.7759/cureus.18852] [Reference Citation Analysis]
10 Smit KN, Jager MJ, de Klein A, Kiliҫ E. Uveal melanoma: Towards a molecular understanding. Prog Retin Eye Res 2020;75:100800. [PMID: 31563544 DOI: 10.1016/j.preteyeres.2019.100800] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 8.3] [Reference Citation Analysis]